Topic: sterile injectables
The American Hospital Association has crafted a lengthy list of suggestions for addressing drug shortages that include both the carrot and the stick.
FDA slaps Akorn with warning letter following an inspection of its sterile injectables plant in Illinois.
Pfizer's plan to close two legacy Hospira plants in India puts 1,700 jobs stationed there at risk.
The most recent inspection of Pfizer's troubled injectables plant in McPherson, Kansas, found eight observations, seven of them repeats.
Management at Dr. Reddy’s oncology drug plant isn’t getting the FDA's message. A recent inspection found five of eight observations were repeats.
Abzena will invest $20 million in a cell manufacturing facility, and Catalent is spending $2.5 million on a clinical supply facility in China.
Big Pharma firms touted growth in China; Genentech sues ex-staffers and biosim company; Janssen licenses Yuhan's potential Tagrisso rival.
Hikma, which has established itself as a top sterile injectables manufacturer in the U.S., is now picking up a production plant in Vietnam.
Pfizer acknowledged that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill for U.S. hospitals.
Aspen Pharmacare says it will invest nearly $235 million in a facility to manufacture sterile anesthetics.